Trump administration agrees to reconsider frozen and shut...

What’s Happening

Not gonna lie, NIH agrees to reevaluate research projects left in bureaucratic limbo while a lawsuit over termination of DEI-related grants moves through the courts Biotech Biotech FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access By Elaine Chen Politics Politics STAT Plus: White House unveils largest batch of drug pricing agreements yet By Daniel Payne and John Wilkerson Health Health In major effort to end gender-affirming care, Trump administration takes aim at hospitals By Theresa Gaffney , Daniel Payne , and Chelsea Cirruzzo Politics Politics House passes health care bill to boost access to workplace insurance By John Wilkerson Pharma Pharma STAT Plus: More drugmakers set to sign pricing deals with Trump on Friday By Daniel Payne STAT Plus: China biotech’s Cambrian explosion By Brian Finrow STAT Plus: I’m the former head of Pfizer R&D.

I’m worried about biopharma’s future By John L. (plot twist fr)

Why This Matters

Health experts are weighing in on what this means for people.

Medical professionals are taking note of this development.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

We want to hear your thoughts on this.